These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4999877)

  • 1. Development of vaccines for coccidioidomycosis.
    Levine HB; Pappagianis D; Cobb JM
    Mycopathol Mycol Appl; 1970; 41(1):177-85. PubMed ID: 4999877
    [No Abstract]   [Full Text] [Related]  

  • 2. Deficient resistance to Coccidioides immitis following intravenous vaccination. II. Evidence against an immune tolerance mechanism.
    Scalarone GM; Levine HB
    Sabouraudia; 1971 Jul; 9(2):90-6. PubMed ID: 4939207
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel strategies to enhance vaccine immunity against coccidioidomycosis.
    Cole GT; Hung CY; Sanderson SD; Hurtgen BJ; Wüthrich M; Klein BS; Deepe GS; Ostroff GR; Levitz SM
    PLoS Pathog; 2013; 9(12):e1003768. PubMed ID: 24367252
    [No Abstract]   [Full Text] [Related]  

  • 4. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
    Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
    Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient resistance to Coccidioides immitis following intravenous vaccination. I. Distribution of spherules after intravenous and intramuscular doses.
    Scalarone GM; Levine HB
    Sabouraudia; 1971 Jul; 9(2):81-9. PubMed ID: 5111562
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines.
    Walch HA; Kalvoda A
    Sabouraudia; 1971 Nov; 9(3):173-84. PubMed ID: 5135085
    [No Abstract]   [Full Text] [Related]  

  • 7. Deficient resistance to Coccidioides immitis following intravenous vaccination. 3. Humoral and cellular responses to intravenous and intramuscular doses.
    Levine HB; Scalarone GM
    Sabouraudia; 1971 Jul; 9(2):97-108. PubMed ID: 5111563
    [No Abstract]   [Full Text] [Related]  

  • 8. Attributes of deficient immunity in mice receiving Coccidioides immitis Spherule vaccine by the intravenous route.
    Scalarone GM; Levine HB
    Sabouraudia; 1969 Oct; 7(3):169-77. PubMed ID: 5385153
    [No Abstract]   [Full Text] [Related]  

  • 9. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
    Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
    Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity in coccidioidomycosis.
    Cox RA; Magee DM
    Res Immunol; 1998; 149(4-5):417-28; discussion 506-7. PubMed ID: 9720959
    [No Abstract]   [Full Text] [Related]  

  • 11. Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities.
    Pappagianis D
    Fungal Genet Biol; 2001 Feb; 32(1):1-9. PubMed ID: 11277621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vaccine against coccidioidomycosis is justified and attainable.
    Cole GT; Xue JM; Okeke CN; Tarcha EJ; Basrur V; Schaller RA; Herr RA; Yu JJ; Hung CY
    Med Mycol; 2004 Jun; 42(3):189-216. PubMed ID: 15283234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines against Coccidioides.
    Yoon HJ; Clemons KV
    Korean J Intern Med; 2013 Jul; 28(4):403-7. PubMed ID: 23864796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
    Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
    Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of mice against coccidioidomycosis with a subcellular vaccine.
    Pappagianis D; Hector R; Levine HB; Collins MS
    Infect Immun; 1979 Jul; 25(1):440-5. PubMed ID: 478645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
    Hurtgen BJ; Hung CY
    Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spherule coccidioidin in delayed dermal sensitivity reactions of experimental animals.
    Levine HB; Cobb JM; Scalarone GM
    Sabouraudia; 1969 Feb; 7(1):20-32. PubMed ID: 5375339
    [No Abstract]   [Full Text] [Related]  

  • 18. The Rise of
    Van Dyke MCC; Thompson GR; Galgiani JN; Barker BM
    Front Immunol; 2019; 10():2188. PubMed ID: 31572393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
    Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
    Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen.
    Lecara G; Cox RA; Simpson RB
    Infect Immun; 1983 Jan; 39(1):473-5. PubMed ID: 6822433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.